Acadia Pharmaceuticals (ACAD) Other Working Capital Changes (2010 - 2026)

Acadia Pharmaceuticals' Other Working Capital Changes history runs 17 years deep, the most recent figure standing at -$2.2 million for Q1 2026.

• On a quarterly basis, Other Working Capital Changes fell 76.19% year-over-year to $5000.0 in Q1 2013; TTM through Mar 2013 was -$247000.0, a N/A change from a year earlier, with the FY2017 full-year figure at -$2.6 million, down 200.0% from the prior year.
• Other Working Capital Changes improved to $5000.0 in Q1 2013 per ACAD's latest filing, from -$149000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $21000.0 in Q1 2012 and bottomed at -$149000.0 in Q3 2012.
• The 5-year median for Other Working Capital Changes is $195000.0 (2024), against an average of $617533.3.
• Across the five-year window, Other Working Capital Changes jumped 843.08% in 2025 and tumbled 691.6% in 2026, its largest moves.
• Year by year, Other Working Capital Changes stood at -$149000.0 in 2012, then soared by 103.36% to $5000.0 in 2013.
• Per Business Quant, the three latest ACAD Other Working Capital Changes figures stand at $5000.0 (Q1 2013), -$149000.0 (Q3 2012), and -$124000.0 (Q2 2012).